Study on production of region-specific antibodies against brain-gut hormones
Study on production of region-specific antibodies against brain-gut hormones
批准号:
63870093
负责人:
YANAIHARA Noboru
金额:
$4.16万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989
中文摘要
脑肠激素的合成:我们已经合成了几种脑肠激素和含有15-20个氨基酸残基的相关肽。这些肽的合成是根据固相技术进行的,使用自动合成的肽,贝克曼模型990。在PAM树脂(Applied Biosystems)上构建了保护肽链。合成肽的纯度通过酸水解物和AP-M酶切物的氨基酸分析、C_<18>反相高效液相色谱分析和自动气相测序仪(Applied Biosystem 470A)的序列分析得到证实。本研究合成了猪、大鼠甘丙肽、helodermin、豚鼠VIP、大鼠PHI、人胰高血糖素样肽-1 (GLP-1)、人NPY、人、大鼠prolh - rh相关肽、促性腺激素释放激素相关肽(GAP)等几种新型脑肠激素。选择GLP-1特异性抗血清、合成GLP-1(7-22)型猪甲状腺球蛋白结合型和合成GLP-1(1-35)型非结合型作为免疫原,分别免疫兔。所得抗血清,抗GLP-1(7-22)血清RO322和抗GLP-1(1-35)血清RO351,用于开发GLP-1区域特异性放射免疫测定(RIA)系统。丙氨酸:由于丙氨酸的c端结构与速激肽相似,因此成功制备了一种针对合成猪丙氨酸(1-15)的单克隆抗体,专门用于免疫组织化学研究。事实上,这种单克隆抗体被发现能够特异性识别产生丙氨酸的细胞,并且不会与任何速激肽发生交叉反应。前LHRH相关肽:已知LHRH前体含有LHRH和一个56个氨基酸的GAP肽。利用合成的GAP(34-56)和proLHRH(1-26),我们开发了人促lhrh羧基和氨基末端特异性RIA,并生产了抗GAP(34-56)血清(RO242)和抗proLHRH(1-26)血清(RO620)。在家兔中制备了抗合成大鼠GAP(28-51) (RO246)的血清。少
英文摘要
Synthesis of brain-gut hormones: We have synthesized several brain- gut hormones and the related peptides containing 15-20 amino acid residues. Syntheses of these peptides were performed according to solid phase technology using an automated peptide synthesized, Beckman Model 990. A protected peptide chain was constructed on a PAM resin (Applied Biosystems). The purity of the synthetic peptides was proved by amino acid analyses of both acid hydrolysates and AP-M digests of the peptides, analytical C_<18> reverse-phase HPLC and the sequence analysis of the peptide using an automated gas-phase sequencer (Applied Biosystem 470A)., We have synthesized in the present study several new brain-gut hormones such as porcine and rat galanin, helodermin, guinea pig VIP, rat PHI, human glucagon-like peptide-1 (GLP-1), human NPY human and rat proLH-RH-related peptide such as gonadotropin releasing hormone-associated peptide (GAP).Production of antisera against brain-gut hormoned: GLP-1 for productio … More n of GLP-1 specific antisera, synthetic GLP-1(7-22) in porcine thyroglobulin-conjugated form and GLP-1(1-35) in non-conjugated form were selected as immunogens and rabbits were immunized with each of the immunogens. The resulting antisera, anti-GLP-1(7-22) serum RO322 and anti-GLP-1(1-35) serum RO351, were used for the development of radioimmunoassay (RIA)-systems region-specific for GLP-1.Galanin: Since galanin has structural similarities in its C-terminal region to tachykinins, a monoclonal antibody against synthetic porcine galanin(1-15) was successfully produced especially for immunohistochemical study. In fact, this monoclonal antibody was found to recognize specifically galanin-producing cells and did not cross-react with any of tachykinins.Pro-LHRH related peptide: LHRH precursor has been known to contain LHRH and a GAP with 56 amino acid peptide. Using synthetic GAP(34-56) and proLHRH(1-26), we have developed human pro-LHRH carboxy- and amino- terminal specific RIA with the production of anti GAP(34-56) serum(RO242) and anti-proLHRH(1-26) serum (RO620). An antiserum against synthetic rat GAP(28-51) (RO246) was also generated in a rabbits. Less
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Gauweiler,B.;Yanaihara,N.;et al.: Neurosci.Lett.89. 121-126 (1988)
Gauweiler,B.;Yanaihara,N.;等人:Neurosci.Lett.89。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Zhang,et al.: "Gonadotropin-releasing hormone-associated peptide in rat brain tissues" Biomed.Res.10. 371-375 (1989)
T.Zhang,et al.:“大鼠脑组织中促性腺激素释放激素相关肽”Biomed.Res.10。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
矢内原昇: "放射線医学大系" 中山書店, 190-210 (1988)
柳原登:《放射医学系统》中山书店,190-210(1988)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N. Yanaihara and C. Yanaihara: "Synthesis of gastrointestinal hormones using organic chemical or recombinant DNA techniques." Advances in Metabolic Disorders, 11 141-162, 1988.
N. Yanaihara 和 C. Yanaihara:“使用有机化学或重组 DNA 技术合成胃肠激素。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.yanaihara編: "Peptide Chemistry 1989" Protein Researeh Foundation, 1-407 (1989)
N.yanaihara 编辑:“Peptide Chemistry 1989”蛋白质研究基金会,1-407 (1989)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
The role of neuropeptide reseptor and its antagonists
-
批准号:06044190
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.43万
-
财政年份:1994
-
负责人:YANAIHARA Noboru
-
依托单位:
Study on superagonist and antagonist of brain-gut peptide
-
批准号:03454520
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.65万
-
财政年份:1991
-
负责人:YANAIHARA Noboru
-
依托单位:
Joint study on design, synthesis and analysis of agonists and antagonists of galanin
-
批准号:03044120
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.12万
-
财政年份:1991
-
负责人:YANAIHARA Noboru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
GLP-1多肽原料药质量研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:石炜
-
依托单位:
基于“短链脂肪酸-巨噬细胞极化-GLP-1”途径探究培土育嗣汤防治肥胖型PCOS 并发GDM 的机制
-
批准号:ZCLHDMY26H0401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈雪琴
-
依托单位:
GLP-1/GIP受体双激动剂联合动态血糖监测对糖尿病脑病的作用研究
-
批准号:2026JJ81501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨丽
-
依托单位:
透明质酸促进短链脂肪酸生成下调HIF1α及GLP-1表达改善代谢功能相关脂肪性肝病的机制研究
-
批准号:2026JJ70120
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐艳华
-
依托单位:
GLP-1 受体激动剂通过增强眼类淋巴功能改善青光眼神经节细胞损伤的分子机制研究
-
批准号:ZCLHDMY26H1201
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:童路遥
-
依托单位:
丁酸通过GLP-1信号介导的“肠-皮轴”调控皮肤屏障与免疫稳态改善银屑病的机制研究
-
批准号:2026JJ70127
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李雅嘉
-
依托单位:
GLP-1/GIP通过改善线粒体损伤缓解阿霉素心脏毒性的作用和机制研究
-
批准号:2026JJ82638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:欧阳玉
-
依托单位:
GLP-1通过LKB1/AMPK调控STING改善晚期糖基化终末产物诱导人主动脉内皮细胞铁死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡珂昕
-
依托单位:
GLP-1受体激动剂通过肠道菌群代谢产物SCFAs抑制PI3K/AKT/NF-κB信号通路抑制糖尿病肾病机制进展研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:钟晨瑜
-
依托单位:
基于人工智能的多靶点 GLP-1 药物设计与药理药效机制解析
-
批准号:25TS1400700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨德华
-
依托单位: